OEM News

ForSight Robotics Reports 1st Robotic Cataract Surgery with JASPER Platform

The JASPER platform helps surgeons with every step, providing them with advanced imaging, precision, and motion scaling.

Author Image

By: Sam Brusco

Associate Editor

ForSight Robotics, a pioneer in robotic eye surgery, revealed successful completion of the world’s first fully robot-assisted cataract surgery done in a human patient using its JASPER platform. The surgery was performed by Dr. Alexey Rapoport, with Dr. Robert Edward T. Ang of the Asian Eye Institute in Manila serving as principal investigator.

“This is a defining moment for ophthalmic surgery and the future of global healthcare,” said Dr. Joseph Nathan, ForSight Robotics’ co-founder, president, and CMO. “With the first successful full robotic cataract procedure in a human patient, this achievement opens the door to dramatically expanding access to sight-restoring surgery for millions around the world.”

Previous ophthalmic robotic procedures only performed partial tasks during cataract surgery, and under general anesthesia. ForSight completed a cataract surgery without needing general anesthesia, which aligns with current standard practice of modern cataract procedures.

The JASPER platform (formerly the ORYOM platform) was built to optimize conventional cataract surgery’s workflow and feel. It helps surgeons with every step, providing them with advanced imaging, precision, and motion scaling to reduce fatigue and variability between procedures.

“Performing the first-in-human cataract surgery with the JASPER Platform has been the highlight of my career,” said Dr. Alexey Rapoport. “Something we could only dream about a few years ago is now a reality. Standing in the operating room, it was clear we were witnessing the future of eye surgery.”

ForSight said the platform and surgeon work in harmony to offer advanced dexterity, aimed at safer and more accurate outcomes. The approach hopes to extend the careers of ophthalmic surgeons who commonly have musculoskeletal disorders caused by sustained awkward operating postures.

This achievement build on the company’s successful Series B funding last year. ForSight said it will now move toward clinical validation and regulatory submissions.

“This milestone represents more than a technical achievement. ForSight Robotics is re-envisioning how eye surgery is done and opening the door to greater standardization across procedures, improved precision, and broader access to vision-saving care,” said Dr. Fred Moll, founder of Intuitive Surgical and Auris Health and ForSight Robotics investor and board member.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics